ENTITY
Xiamen Amoytop Biotech Co Ltd

Xiamen Amoytop Biotech Co Ltd (688278 CH)

37
Analysis
Health Care • China
Xiamen Amoytop Biotech Co., Ltd. operates as a drug development company. The Company develops and sells protein drugs, interferon drugs, and other products. Xiamen Amoytop Biotech markets its products primarily throughout China with limited overseas.
more
•05 Aug 2026 03:43

Primer: Xiamen Amoytop Biotech Co Ltd (688278 CH) - Aug 2026

Xiamen Amoytop Biotech is a high-growth, profitable biopharmaceutical company with a strong focus on recombinant protein drugs, particularly for...

Logo
98 Views
Share
•23 Aug 2026 10:15

A-Share Margin Trading Weekly (Aug 21st): COSCO SHIPPING, EAST MONEY INFORMATION, Mindray, CNOOC

We analyzed A-share margin trading positions report for the past week and highlighted COSCO SHIPPING, EAST MONEY INFORMATION, Mindray, CHENGDU...

Logo
116 Views
Share
•16 Aug 2026 10:15

A-Share Margin Trading Weekly (Aug 14th): SHANGHAI GENTECH, TCL, JIANGSU HENGRUI MEDICINE, CSSC

We analyzed A-share margin trading positions report for the past week and highlighted SHANGHAI GENTECH, TCL, JIANGSU HENGRUI MEDICINE, CSSC, CMOC.

Logo
108 Views
Share
•15 Jul 2026 14:23

STAR50 Jun 2026 Index Rebalance: Post-Implementation Review

STAR50 Jun 2026 rebalance has passed the first post-implementation month. We review what worked, what did not, and how current results compare with...

Logo
145 Views
Share
•01 Jul 2026 12:20

STAR50 Index Earning Revision (Jun): SANY RENEWABLE ENERGY, NATIONAL SILICON INDUSTRY, MGI TECH

We analyzed STAR50's consensus for Jun 2026 and highlighted changes of EPS in SANY RENEWABLE ENERGY (688349 CH), NATIONAL SILICON INDUSTRY (688126...

Logo
142 Views
Share
x